MDNA11 continues to show best-in-class potential in the ABILITY-1 study with an objective response rate (ORR) of 30% in the monotherapy dose expansion cohort among patients with cancer progression ...

MDNA11 continues to show best-in-class potential in the ABILITY-1 study with an objective response rate (ORR) of 30% in the monotherapy dose expansion cohort among patients with cancer progression aft ...

Organization is the unsung hero of email marketing success, and it's especially important during the busiest times of the ...

Patients with MSI-high/dMMR advanced colorectal cancers had a 79 percent lower risk of disease progression or death on Opdivo-Yervoy compared to chemo.

Is AMD's hot new Ryzen 7 9800X3D gaming CPU going into meltdown? Two reports from gamers experiencing dramatic CPU "burn outs ...

While the components inside are top-notch on paper, in the real world the Titan 18 HX makes very little sense. It's ...

Orange, CA, November 15, 2024-M S International, Inc. (MSI), the supplier of flooring, countertops, wall tile, and ...